COVID-19 Outcomes in Critically Ill Patients in New York City
In patients admitted to the hospital with COVID-19 in New York City, critical illness is common and associated with high frequency of invasive mechanical ventilation.
News
LATEST NEWS
Proposed Palliative Care Response Plans During the COVID-19 Pandemic
Clinicians have proposed a system-wide response plan for the delivery of high-quality palliative care across a continuum of conventional, contingency, and crisis capacity scenarios during the COVID-19 pandemic.
Merck Collaborating on Novel COVID-19 Vaccine, Oral Antiviral
The vaccine candidate is currently in preclinical development with clinical studies expected to begin later this year.
Clinical, Anatomic Improvements With Dupilumab in Eosinophilic Esophagitis Study
Dupilumab was associated with clinical and anatomic improvements in patients with eosinophilic esophagitis, according to results from a pivotal phase 3 study.
WHO Suspends Testing of Hydroxychloroquine in Patients With COVID-19
In light of recent findings, the hydroxychloroquine arm of the WHO global study has been paused temporarily.
Air Filters Shown to Improve Breathing in Children With Asthma
Daily in-bedroom use of a PM2.5 filter resulted in significant improvement of airway mechanics.
Case Study: Typical Progression of COVID-19 in Metastatic Lung Adenocarcinoma
A case study of an older man with metastatic lung adenocarcinoma who presented with symptoms of COVID-19 demonstrated patients with cancer have a similar COVID-19 disease progression as the general population.
Lung Ultrasound B-Lines May Predict Pulmonary Deterioration in Systemic Sclerosis
Lung ultrasound B-lines can depict modifications in the lung parenchyma of patients with systemic sclerosis and may be an independent predictor of additional pulmonary deterioration in individuals with the disease.
UPCOMING MEETINGS
FEBRUARY 22-25
American Academy of Allergy, Asthma and Immunology (AAAAI) 2019 Annual Meeting
San Francisco, CA
February 27-28
5th International Conference on Respiratory and Pulmonary Medicine
Paris, France
April 10-13
ELCC 2019: European Lung Cancer Conference
Geneva, Switzerland
DRUG NEWS FROM MPR
Brigatinib Approved as First-Line Treatment for ALK-Positive Metastatic NSCLC
Umbilical Cord Stem Cell Therapy to Be Assessed in Severe COVID-19
FDA: Scammers Continue to Sell Unproven Products for COVID-19
Drug Shortages Reported as New Program Created to Expedite Treatments for COVID-19
FDA Approves Imfinzi for Extensive-Stage Small Cell Lung Cancer
FDA: Studies Underway to Evaluate Chloroquine for COVID-19
Pirfenidone Gets Breakthrough Therapy Status for Unclassifiable Interstitial Lung Disease
FDA: Cases of Respiratory Depression With Gabapentinoids Reported
New Cheek Swab Helps Rule Out Genetic Form of COPD
FDA Panel Votes on OTC Nicotine Mouth Spray for Smoking Cessation
Mepolizumab Approved for Younger Patients With Severe Eosinophilic Asthma
Fixed-Dose, Triple-Combination Therapy Effective in COPD Trial
Nangibotide Gets Fast Track Status for Treatment of Septic Shock
Rovalpituzumab Tesirine Program Ends After Poor Results in Lung Cancer Trial
Entrectinib Receives FDA Approval for Non-Small Cell Lung Cancer
Want to read more?
Please login or register first to view this content.
Next post in News
